Industry & Research
Pharma & biotech
For teams exploring how molecular alterations relate to drug sensitivity, resistance and biological response.
Example research questions
Questions this context might explore
The kinds of questions we explore together in this context.
- How do selected tumour alterations behave in a biological model when candidate compounds are applied?
- Which resistance-associated alterations co-occur with a target of interest?
- How is the evidence linking an alteration to a therapy distributed across tumour types?
Fit with each offering
Twin and AVATAR, separately
OnKommon Twin
Twin's analytical architecture — particularly AccessMatch, ResistMap and TrialGraph — organises evidence around alterations and therapies. Any research use of Twin outputs would be scoped and governed separately.
The 21 analytical layersOnKommon AVATAR
AVATAR combines computational interpretation with mutation-informed Drosophila modelling and candidate-drug screening for solid-tumour WES research questions.
AVATAR overviewDefined in scoping
What a collaboration would define
- Research question and endpoints
- Candidate compounds in scope
- Data inputs and confidentiality
- Deliverables and reporting format
- Publication and IP terms
- Timelines
Other contexts: Diagnostics · Clinical development · Academic research